Valuation: Balchem Corporation

Market Cap 5.31B 4.72B 4.4B 4.01B 7.57B 510B 7.64B 53.29B 20.65B 261B 19.93B 19.5B 837B P/E 2026 *
30.8x
P/E 2027 * 29.6x
Enterprise Value 5.35B 4.75B 4.43B 4.04B 7.62B 514B 7.69B 53.64B 20.79B 263B 20.07B 19.63B 843B EV / Sales 2026 *
4.72x
EV / Sales 2027 * 4.41x
Free-Float
99.51%
Yield 2026 *
0.7%
Yield 2027 * 0.78%
1 day+1.75%
1 week-0.79%
Current month+0.97%
1 month-5.08%
3 months-1.33%
6 months-2.26%
Current year+8.61%
1 week 161.05
Extreme 161.0501
168.77
1 month 161.05
Extreme 161.0501
172.53
Current year 152.58
Extreme 152.58
183.9
1 year 139.17
Extreme 139.17
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 67.71
Extreme 67.71
186.03
Manager TitleAgeSince
Chief Executive Officer 61 2015-04-27
Director of Finance/CFO 49 2019-02-03
Chief Tech/Sci/R&D Officer 56 2025-09-30
Director TitleAgeSince
Director/Board Member 63 2010-09-15
Chairman 61 2016-12-31
Director/Board Member 59 2015-09-14
Date Insider Type Main position Quantity % Market Cap. Importance
4/1/26 Other

Controller/Auditor

8,646 0.0270%
2/11/26 Free

Director

870 0.0027%
2/11/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
+1.75%-0.79%+13.88%+35.33% 5.31B
+0.90%-2.07%-0.11%+63.99% 76.73B
+0.60%-2.52%+3.83%+14.29% 37.4B
+2.60%+0.38%+3.08%-20.09% 35.56B
+0.53%-1.95%+3.55%+6.98% 31.26B
+0.73%-1.96%+6.72%+50.40% 29.2B
-2.33%-3.91%-8.20%+14.95% 25.12B
+1.46%+1.52%+45.88%+35.56% 23.49B
+0.62%-3.54%+44.60%+14.72% 18.43B
+0.60%-1.31%-46.50%-40.91% 17.55B
Average +0.75%-1.88%+6.67%+17.52% 30.01B
Weighted average by Cap. +0.76%-1.80%+5.01%+24.57%

Financials

2026 *2027 *
Net sales 1.13B 1.01B 938M 855M 1.61B 109B 1.63B 11.36B 4.4B 55.61B 4.25B 4.16B 178B 1.2B 1.06B 992M 904M 1.7B 115B 1.72B 12B 4.65B 58.77B 4.49B 4.39B 189B
Net income 175M 155M 145M 132M 249M 16.81B 252M 1.75B 680M 8.59B 656M 642M 27.58B 182M 162M 151M 138M 260M 17.52B 262M 1.83B 709M 8.96B 684M 669M 28.74B
Net Debt 35.51M 31.55M 29.45M 26.84M 50.62M 3.41B 51.09M 356M 138M 1.75B 133M 130M 5.6B -39.68M -35.25M -32.9M -29.99M -56.56M -3.81B -57.09M -398M -154M -1.95B -149M -146M -6.26B
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
26-10-02 $166.56 +1.75% 197,319
26-10-01 $163.69 -0.77% 252,579
26-09-30 $164.96 -1.31% 181,061
26-09-29 $167.15 -0.91% 234,679
26-09-28 $168.68 +0.47% 172,546
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
166.56USD
Average target price
209.25USD
Spread / Average Target
+25.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BCPC Stock